• HOME
  • PARTNERS
  • NEWS
    • NEWSLETTER
  • JOINT CALLS
    • JOINT TRANSNATIONAL CALL 2022
    • JOINT TRANSNATIONAL CALL 2021
    • JOINT TRANSNATIONAL CALL 2020
    • JOINT TRANSNATIONAL CALL 2019
    • JOINT TRANSNATIONAL CALL 2018
  • FUNDED PROJECTS
  • EP PerMed
    • Draft Proposal “European Partnership on Personalised Medicine”
    • EP PerMed Information Day
    • EP PerMed Information Sheets
    • Guide to a European Partnership for Personalised Medicine
    • Draft Concept Paper “European Partnership for Personalised Medicine – EP PerMed”
  • PRIVACY
  • FOLLOW US
  • ACCESS FOR MEMBERS
03 May2022

1st First EU Africa PerMed Webinar: “Oncology: Personalised Medicine approach”

Written by Mª Cristina Nieto. Posted in News

Cancer is a major public health problem worldwide and is expected to surpass infectious disease as the leading cause of mortality in Africa within the next two decades.

It is a group of genomic diseases that presents with intra- and inter-population unique phenotypes. At large, the prevention and personalized treatment of cancers have been driven by the understanding of the genetic make-up of the disease of mostly non-African populations. For this, it is needed to address the knowledge gap in understanding the underlying genetic causes of, and genomic alterations associated with, cancer among black Africans.

Lastly, it is related to disparities that include socioeconomic, ethnic, racial, and cultural factors that differ between low and high-income countries.


Retinoblastoma is the most common cancer in the paediatric population and Wilms tumor (WT) is the most common renal malignancy of childhood. Both with global disparities reported indicating highest incidence and lowest survival in sub-Saharan Africa.

Recently studies are focused on identifying the constitutional mutations within the African populations.

  • Continue Reading
19 Apr2022

Upcoming Events related to Personalised Medicine

Written by Mª Cristina Nieto. Posted in News

For your information, there will be several upcoming events related to personalised medicine in April and May:

  • SAPHIRE final event: Personalised Medicine in European Regions – A Roadmap to the Future of Medicine, 25&26.04.2022, Brussels.
  • HEcoPerMed Final Conference, on-site and streaming on 28.04.2022.
  • EU-STANDS4PM Annual meeting, virtually, on 18&19.05.2022.
  • 3rd ERA CoBioTech Hub meeting, virtually, on 19.05.2022. Including an ERA PerMed presentation. 
  • 1st EU-Africa PerMed webinar: Oncology: Personalised Medicine approach, virtually, on 17.05.2022
  • 16th Personalised Medicine Conference, California, 19&20.05.2022.

Hoping that they are of your interest!

  • Continue Reading
31 Jan2022

New publication of EU-STANDS4PM

Written by Mª Cristina Nieto. Posted in News

EU-STANDS4PM is a Coordinating and Support Action funded under the Horizon2020 framework programme of the European Commission. Its central goal is to develop harmonised transnational standards, recommendations and guidelines that allow a broad application of predictive in silico methodologies in personalised medicine across Europe.

A new publication of the project is recently available, focused on: Computational Models for Clinical Applications in Personalized Medicine—Guidelines and Recommendations for Data Integration and Model Validation. 

This publication may be of interest of those research groups developing predictive computational models in the field of personalised medicine. 

  • Continue Reading
25 Jan2022

ICPerMed “Best Practice in Personalised Medicine” Recognition 2021

Written by Mª Cristina Nieto. Posted in News

This is the fourth call of ICPerMed “Best Practice in Personalised Medicine” Recognition. The objective of the ICPerMed Recognition 2021 is to honour, encourage, promote and disseminate outstanding evidence-based applications in the field of personalised medicine (PM), focusing on the implementation of PM research. It is open for candidates worldwide. We encourage to present your candidatures if you are interested. 

The deadline for proposal submission is extended until 18th February 2022.

You can consult all the information related with this call here. 

  • Continue Reading
14 Jan2022

Newsletter 7

Written by Mª Cristina Nieto. Posted in NEWSLETTER

ERA PerMed Results of the Joint Transnational Call 2021

We are glad to announce the publication of ERA PerMed 7th Newsletter where you can find detailed description about the selected projects to be funded under ERA PerMed Joint Transnational Call for Proposals 2021 on “Multidisciplinary Research Projects on Personalised Medicine- Development of clinical support tools for personalised medicine implementation”. 

  • ERA PerMed 7th Newsletter January 2022. 

  • Continue Reading
  • 1
  • 2
  • 3
  • 4
  • ...
  • 6

Please follow us on @ERANET_PerMed!

Instituto de Salud Carlos III


 height


This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 779282